Praxis Precision Medicines, Inc. cash flow to debt ratio of -226.43K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Praxis Precision Medicines, Inc.'s free cash flow has decreased 89.08% from $-131.76M last year to $-249.12M, signaling decreasing performance

Praxis Precision Medicines, Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

Praxis Precision Medicines, Inc.'s debt has decreased relative to shareholder equity from 0.00 last year to 0.00 today, signaling strengthened financials

Praxis Precision Medicines, Inc. has a net cash position, so leverage is healthy.

Praxis Precision Medicines, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Praxis Precision Medicines, Inc.'s profit margin has increased (-100.00%) in the last year from -2.14K% to 0.00%, signaling increasing performance

Praxis Precision Medicines, Inc.'s short-term assets of $610.91M exceed its short-term liabilities of $59.77M

Praxis Precision Medicines, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Praxis Precision Medicines, Inc.'s return on equity of -34.15%, is lower than 15.00%, indicating bad performance

Praxis Precision Medicines, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Praxis Precision Medicines, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Praxis Precision Medicines, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Praxis Precision Medicines, Inc. has negative free cash flow, indicating cash burn

Praxis Precision Medicines, Inc.'s yearly earnings has decreased 65.88% since last year from $-182.82M to $-303.27M, signaling decreasing performance

Praxis Precision Medicines, Inc.'s yearly revenue has decreased 100.00% since last year from $8.55M to $0.00, signaling decreasing performance

ROIC -28.18% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Praxis Precision Medicines, Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

Praxis Precision Medicines, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Praxis Precision Medicines, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Praxis Precision Medicines, Inc. has insufficient data to evaluate this check.

Praxis Precision Medicines, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Praxis Precision Medicines, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Praxis Precision Medicines, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Praxis Precision Medicines, Inc. has insufficient data to evaluate this check.

Praxis Precision Medicines, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Praxis Precision Medicines, Inc. has a price-to-book ratio of 7.97x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Praxis Precision Medicines, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue